Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Director/PDMR Shareholding

9 Oct 2012 07:57

RNS Number : 2407O
PureCircle Limited
09 October 2012
 



PURECIRCLE LIMITED

("PureCircle" or "the Company")

 

Dealings in Shares

 

PureCircle (LSE: PURE), the world's leading producer and marketer of high purity stevia ingredients was notified today of the following purchases of shares from the open market by certain Directors:-

 

Director Number of shares Price per share Date of purchase

purchased

 

Mr. Peter Lai Hock Meng 1,000 GBP2.10 7 October 2012

Mr. Peter Lai Hock Meng 9,000 GBP2.15 8 October 2012

Mr. Tan Boon Seng 10,000 GBP2.135 8 October 2012

 

Mr. Tan Boon Seng shares were acquired indirectly through Wang Tak Company Limited ("Wang Tak"), a wholly owned company of Lee Hing Development Limited where he is a substantial shareholder.

 

Following the above purchases, the interests held by these Directors in the Company comprised:-

 

Mr. Peter Lai Hock Meng: 168,600 ordinary shares and 11,700 share options

Mr. Tan Boon Seng: 20,094,150 ordinary shares, all held indirectly through Wang Tak

 

9 October 2012

 

Enquiries:

PureCircle Limited (www.purecircle.com)

Magomet Malsagov, CEO

+60 3 2166 2206

William Mitchell, CFO

+44 7974 005 163

RFC Ambrian Ltd (NOMAD)

+61 8 9480 2500

Stephen Allen

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLIFERIELAIIF
Date   Source Headline
6th Jul 20157:00 amRNSPRECLOSE PERIOD UPDATE FY 2015
24th Apr 20157:00 amRNSAcquisition of remaining equity interest in PCJX
13th Apr 20157:23 amRNSDealings in Shares
10th Apr 20157:00 amRNSExercise of Options and Movement Treasury Shares
16th Mar 20157:00 amRNSInterim Results
9th Mar 20157:00 amRNSAnnouncement of Interim Results
28th Jan 20157:00 amRNSSustainability Report
27th Jan 20157:00 amRNSNotification of a Major Interest
14th Jan 20157:00 amRNSGrant of Options and Movement of Treasury Shares
5th Jan 20157:00 amRNSTrading Update
4th Dec 20147:00 amRNSResult of AGM
21st Nov 20147:00 amRNSHolding(s) in Company
12th Nov 20147:00 amRNSCompletion of Placement
11th Nov 20147:06 amRNSHolding(s) in Company
5th Nov 20147:00 amRNSNotice of AGM and Annual Report
4th Nov 20147:00 amRNSIncrease in Private Placement
22nd Oct 20147:00 amRNSDealings in Shares
21st Oct 20147:00 amRNSPrivate Placement to Support Accelerated Growth
14th Oct 20147:00 amRNSPublication of Annual Report
26th Sep 20147:00 amRNSDirector Share Transfer
19th Sep 20147:00 amRNSGrant of Options and Movement of Treasury Shares
10th Sep 20147:00 amRNSFinal Results
3rd Sep 20147:00 amRNSAnnouncement of Prelims & Investor Conference Call
4th Jul 20147:00 amRNSOptions Granted To and Exercised by Directors
2nd Jul 20147:04 amRNSPRECLOSE PERIOD UPDATE 2H FY 2014
17th Jun 20147:00 amRNSManagement Changes
10th Jun 20147:50 amRNSHolding(s) in Company
8th May 20147:00 amRNSDealings in Shares
2nd May 20147:00 amRNSExercise of Options
25th Apr 20147:00 amRNSDealings in Shares
8th Apr 20147:00 amRNSDirector's Shareholding
28th Mar 20147:00 amRNSExercise of Options
25th Mar 20147:50 amRNSHolding(s) in Company
19th Mar 20147:00 amRNSInterim Results
18th Mar 20147:00 amRNSBoard Change
10th Mar 20147:00 amRNSAnnouncement of Interim Results and Investor Call
10th Jan 20147:00 amRNSOptions Granted To and Exercised by Directors
6th Jan 20147:00 amRNSTrading Update
30th Dec 20137:00 amRNSFDA GRAS "No Objection" for New Rebaudioside M
3rd Dec 20137:00 amRNSResult of AGM
28th Nov 20137:45 amRNSHolding(s) in Company
14th Nov 20137:00 amRNSDealings in Shares
6th Nov 20137:00 amRNSNotice of AGM and Annual Report
8th Oct 20137:00 amRNSLTIP Options Awarded - Options Issued to Directors
16th Sep 20137:00 amRNSFinal Results
3rd Sep 20137:00 amRNSAppointment of Broker and New Financing Facility
2nd Sep 20137:00 amRNSAnnouncement of Prelims & Investor Conference Call
19th Jul 20138:13 amRNSHolding(s) in Company
11th Jul 20137:00 amRNSChange of Brokers
9th Jul 20137:00 amRNSFDA GRAS "No Objection" for New Rebaudioside D

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.